Research Article
Prognostic Factors and Clinical Characteristics of Patients with Primary Duodenal Adenocarcinoma: A Single-Center Experience from China
Table 1
The clinical and pathologic details for resected cases of duodenal adenocarcinoma.
| Characteristics | Number of patients (%) |
| Gender | | Male | 78 (60.9) | Female | 50 (39.1) | Age | | ≤60 years | 72 (56.3) | >60 years | 56 (43.7) | Body mass index, median (range) | | CEA level | | >5 | 17 (15.3) | ≤5 | 94 (84.7) | Tumor location | | D1 | 5 (3.9) | D2 | 113 (88.3) | D3 | 9 (7.0) | D4 | 1 (0.8) | Surgery procedure | | Whipple | 112 (87.5) | Segmental resection | 16 (12.5) | T stage | | T1 | 9 (7.1) | T2 | 25 (19.5) | T3 | 36 (28.1) | T4 | 58 (45.3) | Tumor size | | >5 cm | 27 (21.1) | ≤5 cm | 101 (78.9) | Differentiation | | High | 24 (18.8) | Middle | 60 (46.9) | Low | 44 (34.3) | Vascular invasion | | Yes | 29 (28.4) | No | 73 (71.6) | Perineurial invasion | | Yes | 22 (22.7) | No | 75 (77.3) | Lymph node status | | Positive | 49 (40.5) | Negative | 72 (59.5) | Transfusion | | Yes | 64 (50) | No | 64 (50) | TNM stage (AJCC) | | I | 30 (23.4) | II | 46 (36.0) | III | 52 (40.6) | Recurrence and metastasis | | Yes | 39 (30.7) | No | 88 (69.3) | Adjuvant therapy | | Yes | 48 (37.5) | No | 80 (62.5) |
|
|